Dr Reddy's launches cancer treatment injection in US
The company has launched Bortezomib for Injection 3.5 mg/vial, approved by the United States Food and Drug Administration (USFDA) via a new drug application pathway for intravenous use only, Dr Reddy's Laboratories said in a statement.
Pharma major Dr Reddy's Laboratories on Wednesday said it has launched Bortezomib for Injection 3.5 mg/vial, indicated for the treatment of certain types of cancers in adult patients, in the US market.
The company has launched Bortezomib for Injection 3.5 mg
It’s time to compare and apply for the best loan offers at Afinoz. We are a leading online financial marketplace for Personal Loans
, Business Loan
& Car Loan
and Investment Products. Our system intelligence and the automated system offers the best options to you for the real-time tracking of your loan application in an easy manner. Stay tuned to latest updates in the industry at Afinoz.com